Last reviewed · How we verify
Fluticasone propionate inhaled aerosol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Fluticasone propionate inhaled aerosol (Fluticasone propionate inhaled aerosol) — Xijing Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fluticasone propionate inhaled aerosol TARGET | Fluticasone propionate inhaled aerosol | Xijing Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fluticasone propionate inhaled aerosol CI watch — RSS
- Fluticasone propionate inhaled aerosol CI watch — Atom
- Fluticasone propionate inhaled aerosol CI watch — JSON
- Fluticasone propionate inhaled aerosol alone — RSS
Cite this brief
Drug Landscape (2026). Fluticasone propionate inhaled aerosol — Competitive Intelligence Brief. https://druglandscape.com/ci/fluticasone-propionate-inhaled-aerosol. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab